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THE ASSOCIATIONS OF BONE MINERAL DENSITY AND
BONE TURNOVER MARKERS WITH OSTEOARTHRITIS OF
THE HAND AND KNEE IN PRE- AND PERIMENOPAUSAL WOMEN
MARYFRAN SOWERS, LAURIE LACHANCE, DAVID JAMADAR, MARC C. HOCHBERG,
BRUCE HOLLIS, MARY CRUTCHFIELD, and MARY L. JANNAUSCH
Objective. To determine whether Caucasian
women ages 28–48 years with newly defined osteoarthri-
tis (OA) would have greater bone mineral density
(BMD) and less bone turnover over time than would
women without OA.
Methods. Data were derived from the longitudinal
Michigan Bone Health Study. Period prevalence and
3-year incidence of OA were based on radiographs of the
dominant hand and both knees, scored with the
Kellgren/Lawrence (K/L) scale. OA scores were related
to BMD, which was measured by dual-energy x-ray
absorptiometry, and to serum osteocalcin levels, which
were measured by radioimmunoassay.
Results. The period prevalence of OA (K/L grade
>2 in the knees or the dominant hand) was 15.3% (92 of
601), with 8.7% for the knees and 6.7% for the hand. The
3-year incidence of knee OA was 1.9% (9 of 482) and of
hand OA was 3.3% (16 of 482). Women with incident
knee OA had greater average BMD (z-scores 0.3–0.8
higher for the 3 BMD sites) than women without knee
OA (P < 0.04 at the femoral neck). Women with incident
knee OA had less change in their average BMD z-scores
over the 3-year study period. Average BMD z-scores for
women with prevalent knee OA were greater (0.4–0.7
higher) than for women without knee OA (P < 0.002 at
all sites). There was no difference in average BMD
z-scores or their change in women with and without
hand OA. Average serum osteocalcin levels were lower
in incident cases of hand OA (>60%; P 5 0.02) or knee
OA (20%; P not significant). The average change in
absolute serum osteocalcin levels was not as great in
women with incident hand OA or knee OA as in women
without OA (P < 0.02 and P < 0.05, respectively).
Conclusion. Women with radiographically defined
knee OA have greater BMD than do women without knee
OA and are less likely to lose that higher level of BMD.
There was less bone turnover among women with hand OA
and/or knee OA. These findings suggest that bone-
forming cells might show a differential response in OA
of the hand and knee, and may suggest a different
pathogenesis of hand OA and knee OA.
Osteoarthritis (OA) is a major chronic disease. It
has been estimated to affect 1 in 10 people at age 50 and
.1 in 2 people at age 75 (1). Likewise, osteoporosis
(OP) is a highly prevalent condition that has been
estimated to affect 1 woman in 5 by age 80 (2). Thus, OP
and OA are both common conditions that are more
likely to affect women than men. It is relatively unusual,
however, to find both conditions in the same individual.
Early clinical comparisons showed that elderly
persons undergoing resection of the femoral head to
treat hip OA were much less likely to have evidence of
bone loss than were elderly persons who had femoral
neck fractures (3). Subsequent studies indicated that
persons with OA of the knee or hip were more likely
to have higher bone mass than normal subjects or
subjects with OP (4–6), whereas patients with OA of the
hand might not have greater bone mass (7–9). This
suggests either a difference in the pathogenesis of hand
and knee OA or a possible measurement artifact.
(Greater bone width is associated with generalized OA,
and the definition of bone mass uses bone width in the
assessment of cortical area) (10). Thus, there is evidence
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that the pathogenesis of OA includes mechanisms re-
lated to skeletal calcification.
Hypotheses that have been proposed to explain a
differential association between OA and OP have been
primarily centered around responses to mechanical
forces (11). It has been hypothesized that more stiff
subchondral bone, as reflected by greater bone mass,
increases cartilage damage with normal joint loading,
and leads to the development of OA (11). However,
there may be alternative explanations for the relative
lack of overlap in the presentation of OA and OP,
including genetic makeup (12), differences in response
to changing ovarian hormone levels (13), or differences
in other metabolic factors, such as vitamin D concentra-
tions or growth factors (14–16). Finally, persons who
present with OA may have a differential response of
bone-forming cells over time (17). This may include
enhanced osteoblast production and/or a mineralization
deposition defect, as suggested by the presence of osteo-
phytes and joint space narrowing in some cases with hip
OA (18). Advancing our understanding of this apparent
inverse relationship can enhance our understanding of
the pathophysiology of each disease and the impact of
selecting certain intervention measures.
We evaluated whether pre- and perimenopausal
women with newly defined OA have increased bone
mineral density (BMD). The purposes of this study were
1) to determine if pre- and perimenopausal women with
OA have greater BMD, 2) to determine if there is less
change in BMD among pre- and perimenopausal women
with newly defined OA, and 3) to use longitudinal
osteocalcin levels to determine if there is differential
bone turnover in women with and without OA.
SUBJECTS AND METHODS
Study population. The Michigan Bone Health Study
(MBHS) is a longitudinal study of arthritis and BMD in a
dynamic cohort of Caucasian women in Tecumseh, Michigan.
The MBHS was organized in 1988 to describe the natural
history of peak bone mass, and 542 premenopausal women
ages 20–40 years were recruited for participation. These initial
enrollees represented .80% of the age-eligible female off-
spring listed in the family records of participants from the
historical (1959–1960) Tecumseh Community Health Study
(TCHS). In the ensuing 30 years, those 1960 TCHS family
records no longer reflected all community residents. Thus, an
additional 135 Caucasian women (who now lived in Tecumseh
but whose parents had not been in the original TCHS) were
contacted in 1992 by use of a population-based sampling frame
and, of these, 122 were enrolled in the MBHS. This yielded 664
women (ages 25–45) who were eligible for participation in a
population-based longitudinal study of musculoskeletal char-
acteristics.
Of the 664 women (542 initial enrollees plus 122 later
enrollees) who were eligible for participation in the 1992/93
OA study, 583 were measured for BMD; 81 did not participate
(see Figure 1). Of these 81 nonparticipants, 47 refused, 19 were
pregnant, 5 had severe health conditions, and 10 had moved
from the area. Ten women with BMD measurements did not
have radiographs.
This is a dynamic population, so women who had been
pregnant, had refused participation, or had initially moved
could return for annual examinations (see Figure 1). There
were 602 women in the 1992/93 and/or the 1995/96 arthritis
evaluations, but the denominator was 601 for the period
prevalence, excluding 1 woman with rheumatoid arthritis. The
Figure 1. The status of the dynamic population in the Michigan Bone Health Study at the 1992/93
and 1995/96 examination rounds. BMD 5 bone mineral density.
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denominator for the incidence estimate included 482 women
with hand and knee radiographs and BMD measurements in
both 1992/93 and 1995/96.
OA measurement. During the 1992/93 and 1995/96
annual examinations, anteroposterior (AP) radiographs were
taken of the dominant hand and of both knees bearing weight.
At both time points, films were taken by 1 of 3 trained and
experienced technicians using General Electric radiographic
equipment (model X-GE MPX-80; General Electric Medical
Systems, Milwaukee, WI) and Kodak film (X-DA with Kodak
rare earth intensifying screens; Eastman Kodak, Rochester,
NY). The source film distance was 40 inches, and standard
radiographic techniques were used.
Sixteen joints of the dominant hand and both knee
joints (with weight bearing) were evaluated. Scoring was based
on the Kellgren/Lawrence (K/L) grading system shown in the
Atlas of Standard Radiographs of Arthritis (19). Each joint
was classified according to a 5-point scale (0 5 normal, 1 5
doubtful OA, 2 5 minimal OA, 3 5 moderate OA, and 4 5
severe OA) based on the degree of osteophyte formation,
joint space narrowing, sclerosis, and joint deformity. Apart
from the K/L criteria, joints were classified as unable to
evaluate, missing, or showing changes consistent with rheuma-
toid arthritis.
Standardization of joint grading and evaluation of the
consistency of grading between evaluators followed a multistep
process. The readers reviewed the K/L grading criteria and
evaluated films that were representative of all levels of OA
(20). Then, 50 radiographs of knees and 50 radiographs of
hands from the current study were evaluated independently by
each reader, and their results were compared.
After completing standardization procedures, 2 read-
ers (DJ, MCH, or MFS) independently evaluated and classi-
fied each joint from the 1995/96 radiographs and reread the
1992/93 films. For each joint, the scores assigned by the 2
readers were compared. Joints without perfect correspondence
were reread and, if necessary, subjected to consensus reading.
There were 18,086 joints with perfect concordance and 912
joints that required rereading and/or consensus evaluation.
Kappa statistics indicated that agreement between the initial
score and the consensus score was almost evenly divided
between the 2 readers (21). A group of preselected films,
representative of all levels of OA, were also dispersed through-
out the study films and used to ascertain drift in different days
of reading. There was no evidence of drift.
OA was defined as the presence of at least 1 joint with
a grade of 2 or higher (in the hand and/or the knee). Women
were defined as having hand OA if they had arthritis in any
hand joint, and as having knee OA if they had arthritis in either
or both knees.
BMD and osteocalcin measurements. BMD was mea-
sured annually at 3 sites (proximal femur, lumbar spine, and
total body) using dual-energy x-ray absorptiometry (DXA;
Lunar Corporation, Madison, WI). DXA uses a constant
potential (76 kV[p] x-ray tube with K-edge filtration [350
mg/cm2]) with effective beam energies at 38 keV and 70 keV.
An individual woman’s scanning speed was selected according
to her AP abdominal thickness. Spine phantoms submerged
in 15 cm or 25 cm of tepid water were evaluated at least
weekly to assess drift over the 3-year period. There was no
evidence of drift.
The BMD data are presented as z-scores based on
comparison with the manufacturer’s database (a z-score of
zero is equivalent to the mean value in a young adult female
population). Differences in BMD are the difference be-
tween the individual’s z-score at baseline and the second
BMD z-score at the 3-year followup assessment. This pro-
vides a comparable BMD value for the 3 bone sites whose
absolute values are not comparable. Furthermore, BMD
z-scores are now the standard approach used to delineate
osteopenia and OP.
At annual examinations, blood was drawn during days
3–7 of the follicular phase of the menstrual cycle and after
participants had been fasting for 8 hours. For women without
menses, blood was drawn on the anniversary date of their first
annual examination, while they were fasting. Serum was stored
at 280°C, with no thawing and refreezing prior to assay for
osteocalcin. Osteocalcin levels were measured using a radio-
immunoassay (Incstar, Stillwater, MN) having an inter- and
intraassay variation of ,10%.
Other measurements. Table 1 shows the frequencies of
the variables that characterize the women in the prevalence
group and its subset, the incidence cohort. Two indicator
variables were used to define 3 reproductive status groupings:
1) menstruating women who did not currently use hormone
therapies were the reference group, 2) women without men-
struation in the previous 12 months and without hormone
replacement therapy, and 3) women with hysterectomy or
oophorectomy, with and without hormone replacement ther-
apy. Smoking behavior was described as never smoked, ex-
smoker, or current smoker. The mean (6SD) number of
cigarettes smoked per day by current smokers was 18 6 8.7,
with a range of 1–40 cigarettes per day. Alcohol consumption
was grouped as 1) women currently drinking ,30 gm (,3
drinks) of alcohol per week, and 2) women currently drinking
at least 30 gm of alcohol per week. Injuries were those that
required a visit to the physician’s office, and a qualitative
description was used to gauge seriousness.
Recall of physical activity during the previous week,
previous July, and previous December was recorded and
averaged, and an algorithm modeled on the Stanford Five-City
Table 1. Smoking, menstrual status, and alcohol consumption in pre-







Premenopausal 505 (84) 400 (83)
Postmenopausal 7 (1) 6 (1)
All others† 89 (15) 76 (16)
Smoking status
Never smoked 400 (67) 324 (67)
Ex-smoker 69 (11) 56 (12)
Current smoker 132 (22) 102 (21)
Alcohol intake
,30 gm/week 566 (95) 457 (95)
301 gm/week 33 (5) 25 (5)
* Values are the number (%) of subjects.
† No longer menstruating (includes those with hysterectomy or double
oophorectomy and those using hormone replacement therapy).
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Study instrument (22) was used to indicate average weekly
activity. The values were expressed in METS, with 1 METS
being defined as the energy consumed per minute of sitting at
rest. Height (in centimeters) and weight (in kilograms) were
used to calculate the body mass index (BMI 5 weight [kg]/
height [m2]). This study was approved by the University of
Michigan Institutional Review Board.
Statistical analysis. Period prevalence of OA was
defined using the cases identified in the 1992/93 study and the
new cases in the 1995/96 examination. Incidence of OA was
defined as the number of new cases identified in the 1995/96
evaluations from among the population still at risk for OA
after the 1992/93 evaluation. The 95% confidence intervals
(95% CI) were calculated for both the prevalence and the
incidence.
Kappa statistics were calculated to quantify the extent
to which the observed agreement between the 2 film readers
exceeded that which would have been expected by chance
alone. Because the percentage of agreement might be high due
to the relative absence of women without radiographically
defined OA, the percentage of agreement was calculated with
only the number of women with OA as the denominator (21).
Univariate statistics were calculated for continuous
variables, and frequency tables were developed for categorical
variables. Analysis of variance models were developed to
calculate the least squares mean BMD z-scores. BMD data are
reported as z-values related to the “young adult women” level
and adjusted for covariates, including age, body size, smoking,
and injury, with an analysis of covariance. The significance
level was set as a 2-sided test using a nonparametric approach
(Wilcoxon). Logistic regression analysis was used to consider
whether the probability of having (prevalence) or developing
(incidence) OA was still related to BMD or its 3-year change
after adjusting for covariates such as BMI, smoking, METS of
physical activity, previous injury, or menstrual status.
RESULTS
The overall period prevalence of radiographically
defined OA was 15.3% (92 of 601; 95% CI 12–18%), and
the overall 3-year incidence of radiographically defined
OA was 5.2% (25 of 482; 95% CI 3–7%). Of the 92
women with OA, 74 had grade 2 and 18 had grade 3 or
4 disease. This OA primarily reflects osteophytosis.
Table 2 shows the means (6SD) and ranges for age,
BMI, BMD, and physical activity levels among those
included in the prevalence and incidence estimates.
OA of the knee. The period prevalence of radio-
graphically defined knee OA was 8.7% (52 of 601; 95%
CI 6–11%). The 3-year incidence of knee OA was 1.9%
(9 of 482; 95% CI 0.7–3.0%). There were 48 women with
grade 2 OA and 4 with grade 3 or 4 OA.
The mean 3 BMD z-scores (femur, spine, total
body) of the prevalent cases of knee OA were greater
(z-scores ,0.5 higher) than the mean BMD z-scores of
women without knee OA (P , 0.0001, 0.001, and 0.002
for the femoral neck, lumbar spine, and total body,
respectively). These z-score differences remained statis-
tically significant after adjusting for age, BMI, smoking,
injury, and menstrual status. The three 1995/96 BMD
z-scores remained similar to their 1992/93 BMD z-scores
in women with knee OA (Table 3), whereas the 1995/96
BMD z-scores were lower in women without knee OA,
which indicates bone loss over the 3-year period. This
was statistically significant for the lumbar spine (P ,
0.03).
The average osteocalcin levels were 15% lower in
prevalent cases of knee OA than in women without knee
OA, suggesting less bone turnover (P , 0.14). The mean
3-year change in osteocalcin concentration was lower in
prevalent cases of knee OA. Again, this suggests that
there was less bone turnover in women with knee OA.
Incident knee OA. Incident cases of knee OA had
BMD z-scores that were 0.8, 0.7, and 0.3 SD greater than
the BMD z-scores of women without knee OA at the
femoral neck (P , 0.04), lumbar spine (P , 0.09), and
Table 2. Means, standard deviations, and ranges describing the physical characteristics (measured in 1992/93) of Caucasian women evaluated for





Mean 6 SD Range Mean 6 SD Range
Age, years 37.1 6 5.0 25–46 37.4 6 4.8 25–46
Weight, kg 71.5 6 16.9 44–152 71.2 6 16.8 44–151
Height, cm 163.4 6 5.9 148–180 163.3 6 6.0 148–180
Body mass index, kg/cm2 26.8 6 6.1 16.4–55.5 26.7 6 6.0 16.4–54.1
Bone mineral density
Total body, gm/cm2 1.189 6 0.072 0.702–1.497 1.190 6 0.074 0.702–1.497
Lumbar spine, gm/cm2 1.291 6 0.153 0.866–1.297 1.291 6 0.153 0.866–1.297
Femoral neck, gm/cm2 1.016 6 0.142 0.984–1.410 1.015 6 0.142 0.984–1.410
Physical activity level (METS)* 340 6 56 266–805 339 6 53 266–778
* 1 METS 5 the energy consumed per minute of sitting at rest. See Subjects and Methods for details.
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total body (P , 0.31), respectively (Table 4). Further-
more, incident cases of knee OA were more likely to
retain the same BMD z-scores in 1995/96 (shown in
Table 4 as a positive number in the 3-year BMD z-score
change), whereas the BMD z-scores for women without
knee OA tended to drop.
The average osteocalcin levels were ;20% lower
in incident cases of knee OA, but this difference was not
statistically significant. Over the 3-year period, on aver-
age, bone turnover activity in women with knee OA
declined (20.60 ng/ml). However, bone turnover activity
in women without knee OA tended to be greater over
the 3-year period (10.40 ng/ml).
OA of the hand. The period prevalence of radio-
graphically defined hand OA was 6.8% (41 of 602; 95%
CI 5–9%). The average age of women with prevalent
hand OA was 43.8 years, compared with 39.5 years in
women without hand OA (P , 0.0001). There was no
difference in the BMI among women with and without
hand OA.
The 3-year incidence of hand OA in these women
was 3.3% (16 of 481; 95% CI 2–5%). Of the 41 women
with hand OA, 13 had grade 2 and 18 had grade 3 or 4
disease. The average age of women with incident hand
OA was 44.2 years, compared with 40.2 years in women
without hand OA.
Table 3. BMD z-scores (LS mean 6 SE and range) and their changes and serum osteocalcin levels and their 3-year changes, according to the





P†(LS mean 6 SE) Range (LS mean 6 SE) Range
Age in 1995/96, years 41.6 6 0.7 28, 49 39.7 6 0.2 28, 49 ,0.01
BMD in 1992/93, z-scores
Femoral neck 0.88 6 0.17 22.4, 4.2 0.16 6 0.05 22.1, 3.9 ,0.0001
Lumbar spine 1.30 6 0.19 22.2, 4.9 0.68 6 0.06 21.8, 4.9 ,0.001
Total body calcium 1.16 6 0.13 21.8, 3.9 0.72 6 0.04 21.7, 3.4 ,0.002
3-year BMD change, z-scores
Femoral neck 0.004 6 0.06 20.09, 0.87 20.09 6 0.02 20.80, 0.87 ,0.12
Lumbar spine 0.09 6 0.05 20.56, 1.29 20.023 6 0.02 20.62, 1.09 ,0.03
Total body calcium 20.0002 6 0.04 20.31, 0.97 20.02 6 0.01 20.79, 0.41 ,0.06
Osteocalcin, ng/ml 1.61 6 0.18 0.11, 5.2 1.92 6 0.05 0.19, 5.8 ,0.14
3-year osteocalcin change, ng/ml 20.03 6 0.19 21.28, 6.8 0.38 6 0.06 22.5, 3.0 ,0.07
* z-scores of young normal subjects reflect the manufacturer’s normative database for Caucasian women. A z-score of zero represents the median
value of the distribution of young adult women (adjusted for age, smoking, body mass index, and injury). BMD 5 bone mineral density; OA 5
osteoarthritis; LS 5 least squares.
† Based on Wilcoxon’s 2-sample test.
Table 4. BMD z-scores (LS mean 6 SE and range) at 3 sites and their 3-year changes as well as osteocalcin levels and their 3-year changes,





P†(LS mean 6 SE) Range (LS mean 6 SE) Range
Age in 1995/96, years 41.1 6 1.6 28, 49 40.3 6 0.2 28, 49 ,0.55
BMD in 1992/93, z-scores
Femoral neck 1.01 6 0.40 22.0, 4.2 0.19 6 0.06 22.1, 3.1 ,0.04
Lumbar spine 1.41 6 0.43 22.0, 4.2 0.71 6 0.06 21.74, 3.2 ,0.09
Total body calcium 1.07 6 0.31 21.8, 3.9 0.76 6 0.04 21.3, 2.1 ,0.31
3-year BMD change, z-scores
Femoral neck 0.004 6 0.13 20.90, 0.97 20.09 6 0.02 21.5, 1.42 ,0.54
Lumbar spine 0.37 6 0.11 20.56, 1.30 20.04 6 0.02 20.83, 1.85 ,0.02
Total body calcium 0.04 6 0.08 20.31, 0.96 0.02 6 0.01 20.51, 1.04 ,0.14
Osteocalcin, ng/ml 1.59 6 0.40 0.11, 5.2 1.94 6 0.06 0.55, 5.8 ,0.53
3-year osteocalcin change, ng/ml 20.60 6 0.42 22.28, 3.8 0.40 6 0.06 21.5, 3.0 ,0.05
* z-scores of young normal subjects reflect the manufacturer’s normative database for Caucasian women. A z-score of zero represents the median
value of the distribution of young adult women (adjusted for age, smoking, body mass index, and injury). BMD 5 bone mineral density; OA 5
osteoarthritis; LS 5 least squares.
† Based on Wilcoxon’s 2-sample test.
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There was no difference in the mean BMD levels
(as z-scores) or their 3-year change when comparing
women with prevalent hand OA with women without
hand OA. Likewise, there was no difference in the mean
BMD levels (as z-scores) or their 3-year change when
comparing women with incident hand OA with women
without hand OA.
On average, women with hand OA (either prev-
alent or incident cases), had less active bone turnover.
The average osteocalcin levels were 25–35% lower in
both prevalent (P , 0.007) and incident (P , 0.02) cases
of hand OA, a difference that persisted after adjusting
for age, BMI, smoking, injury, and menstrual status.
Osteocalcin activity increased significantly in
those women without hand OA (10.41 ng/ml), whereas
it declined in women classified as having incident hand
OA (233 ng/ml) (P , 0.03). This remained statistically
significant after adjusting for age, BMI, physical activity,
smoking, and menstrual status.
DISCUSSION
This is a longitudinal study of bone mineral
density, bone turnover, and OA in women ages 28–48
years. Several studies have characterized factors associ-
ated with OA in late middle-aged and elderly popula-
tions (23–26). However, the risk factors identified in
those prevalence studies of the elderly are not posi-
tioned to capture factors that precede the development
of OA. This is particularly true when risk factor infor-
mation, such as bone density or bone turnover, are
unavailable in conventional health records and cannot
be recalled by a respondent.
In this population-based study, we found that
knee OA was associated with greater BMD, consistent
with observations in older populations and in clinical
populations. Furthermore, women with knee OA main-
tained or increased their BMD over a 3-year observation
period compared with women without knee OA. This
was observed even though women with knee OA were
slightly older than those women without knee OA.
The measures of osteocalcin may provide the
evidence of how these higher BMD levels may accrue.
Women with knee OA and/or hand OA had lower bone
turnover, as represented by cross-sectional osteocalcin
concentrations, than did women without OA. Further-
more, women with knee OA and/or hand OA continued
to have less bone turnover, as measured by osteocalcin
levels over a 3-year period, than did women without OA.
This investigation builds upon previous work with
osteocalcin as a marker of bone turnover (17,27,28).
Dequeker et al (27) found more bone and higher levels
of osteocalcin among women with hand OA and con-
cluded that this represented a “stiffer” bone. Sharif et al
(28) associated higher serum osteocalcin levels with
late-phase bone scan abnormalities. Campion et al (17)
suggested that higher levels of serum osteocalcin were
found primarily in a small number of patients with a
destructive OA, and lower levels of serum osteocalcin
were observed in patients with nondestructive OA.
The decreased levels of serum osteocalcin
present in these women who are in the process of
developing OA suggest a differential response of bone-
forming cells in those who have recently developed knee
OA. However, bone turnover would be expected to
increase if, over time, and in selected individuals, the
OA process becomes increasingly destructive.
Because serum osteocalcin may represent the
contribution from multiple skeletal sites, it is important
to question whether serum osteocalcin levels are linked
with osteocalcin concentrations in other tissues more
proximal to the affected joints. Several studies have
reported that serum osteocalcin and synovial fluid os-
teocalcin levels were correlated, albeit the absolute
levels of osteocalcin were significantly lower in the
synovial fluid than in the serum (29,30).
This study, based on data from incident cases,
questions the paradigm that labels women who develop
OA as “bone formers.” That term suggests only an
accelerated capacity to lay down bone. These women
may indeed lay down more mineral or generate more
matrix; however, simultaneously, an important element
to now consider is that their bone cells may not be
turning over as rapidly. This suggests that other factors,
such as a less vigorous osteoclast behavior, differences in
growth-promoting factors, or differential hormone con-
trol of the calcification process, must also be considered.
There are 2 reports which suggest that bone mass
is increased in persons with OA, but that the rate of
bone loss is greater in those with OA (9,31). There are
several potential explanations. The bone loss could be
associated with long-term chronic inflammatory pro-
cesses because the sites measured for bone were also the
sites of localized OA. This includes the cortical area
associated with hand OA in the Sowers et al study (9)
and hip BMD associated with OA of the hip in the
Dequeker et al study (31). The difference could also be
a phenomenon of age. The MBHS population is rela-
tively young and premenopausal, while the other 2 studies
(9,31) were of populations that were older and post-
menopausal.
It is also important to address the limitations of
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the present study. First, serum osteocalcin concentra-
tions reflect systemic concentrations whereas the OA
measures are specific to the joints in the hands and
knees. Bone turnover from the skeleton and bone in
other joint sites could be major, but unmeasured, con-
tributors to the serum osteocalcin levels. Second, while
the woman with RA was eliminated from our analyses,
OA as defined by the K/L scale is not a homogenous
condition and any difference in bone turnover attributed
to OA subsets is not identified in this study. Third,
statistical power is still somewhat limited because of the
relatively few incident cases.
In summary, these data indicate that women ages
28–48 years who have knee OA have greater BMD than
women without knee OA and are less likely to lose that
higher BMD level than are women without knee OA.
Furthermore, osteocalcin levels indicate that there is less
bone turnover in both hand OA and knee OA. These
findings suggest that OA should also be defined as
having a differential response of bone-forming cells with
time, at least in pre- and perimenopausal women. This
suggests that it is no longer adequate to evaluate OA risk
in terms of BMD measures alone.
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